This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Ligand Pharmaceuticals Inc
LGND : NASDAQ : Health Care
$50.27 0.03 | 0.06%
Today's Range: 49.73 - 51.49
Avg. Daily Volume: 445,600
10/21/14 - 12:29 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
LGND LIGAND PHARMACEUTICAL INC 48.86 1015.36 139.60 54.31 31.68
BLUE BLUEBIRD BIO INC 34.82 995.71 n/m 25.39 300.85
AEGR AEGERION PHARMACEUTICALS INC 32.71 966.48 n/m 103.81 1244.54
SRPT SAREPTA THERAPEUTICS INC 22.30 912.61 n/m 15.47 -30.76
MACK MERRIMACK PHARMACEUTICALS 8.69 908.87 n/m 55.53 -5.28
PTLA PORTOLA PHARMACEUTICALS INC 25.90 1232.76 n/m 9.61 269.39
NVAX NOVAVAX INC 5.17 1232.60 n/m 29.27 65.41
HALO HALOZYME THERAPEUTICS INC 9.20 1152.82 n/m 58.86 10.20
ANAC ANACOR PHARMACEUTICALS INC 24.81 1041.92 16.43 19.19 76.12
GHDX GENOMIC HEALTH INC 32.48 1024.00 n/m 272.29 10.74
ARIA ARIAD PHARMACEUTICALS INC 5.36 1002.38 n/m 48.98 137.36
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

LGND Ind Avg S&P 500
139.60 79.53 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs